3rd Annual · Registrations open

The Global HPAPI Summit
for Pharma Leaders

Two intensive days in Rome on containment, regulatory compliance, CDMO partnership and sustainable high-potency manufacturing.

📅
Dates
21–22 April 2027
📍
Venue
Rome, Italy
🏅
Edition
3rd Annual
Scroll
Summit starts in
00
Days
00
Hours
00
Mins
00
Secs
Format 2-Day In-Person Conference
Attendees 150+ Senior Professionals
Speakers 20+ Industry Experts
Focus HPAPI Manufacturing & Containment
Organised By Convolign Business Consulting
0 +
Attendees across pharma, biopharma, CMOs/CDMOs
0 +
Industry expert
speakers
0 +
Companies represented
to date
0 +
Hours of dedicated
networking

Where the HPAPI
Industry Meets

Welcome to the 3rd Annual MaxPotent Pharma Summit, a leading international platform bringing together senior executives, regulatory authorities, technology providers, and pharmaceutical innovators dedicated to advancing the future of Highly Potent Active Pharmaceutical Ingredients (HPAPIs).

This year’s edition builds on the strong foundation of our inaugural summit, with an expanded agenda designed to address the critical challenges and opportunities across the HPAPI value chain. Over two intensive days, the conference will highlight the latest developments in EU and global regulatory frameworks, emerging containment and isolation technologies, and state-of-the-art automation and process engineering that are transforming manufacturing practices.

Delegates will gain actionable insights from real-world case studies, panel discussions, and technical presentations covering occupational health and safety standards, scaling-up strategies, risk-based exposure assessments, and supply chain resilience. Particular emphasis will be placed on partnership models with CDMOs/CMOs, sustainability in high-potency operations, and the integration of digital tools and data-driven decision-making in pharma manufacturing.

Why this programme is different

Our team of producers and analysts invests over a year of preparation to study market dynamics, regulatory changes, and upcoming innovations. This invite-only summit is designed exclusively for HPAPI professionals who want to stay ahead of industry trends and strengthen their expertise. It is the essential platform for knowledge exchange, career advancement, and shaping the future of high-potency drug development.

More about the summit

What the 2027 Programme Covers

Ten themes shape the two-day agenda, from EU regulatory frameworks to digital twins on the shop floor.

01

Evolving EU Regulatory Frameworks

Adapting to the latest EMA and ECHA requirements to ensure compliance in HPAPI production.

02

Innovative Containment Technologies

Designing next-generation facilities with advanced isolators and fully closed systems.

03

Building Supply Chain Resilience

Addressing challenges in sourcing, logistics, and cross-border disruptions affecting HPAPIs.

04

Harnessing AI and Machine Learning

Driving precision manufacturing through real-time analytics and process analytical technologies (PAT).

05

Protecting Workforce & Operations

Applying robust risk assessment methods to safeguard operators and minimise exposure risks.

06

Sustainability in HPAPI Manufacturing

Reducing environmental impact through waste management and alignment with EU Green Deal goals.

Six Reasons to Be in Rome

01

Master EU Regulatory Compliance

Understand the latest EMA and ECHA directives shaping HPAPI manufacturing, containment, and transport.

02

Advance Containment Excellence

Examine state-of-the-art facility designs, isolator systems, and closed technologies that safeguard operators while boosting efficiency.

03

Transform Manufacturing with AI & Automation

See how robotics, machine learning, and Process Analytical Technology (PAT) are redefining high-potency drug production.

04

Build Resilient Supply Chains & CDMO Alliances

Explore strategies for outsourcing, risk management, and reinforcing supply chain continuity across Europe.

05

Drive Sustainability in HPAPI Manufacturing

Implement greener practices in waste reduction, resource efficiency, and regulatory-aligned eco strategies.

06

Learn from Real-World Leaders

Gain practical insights through case studies and direct engagement with senior pharma executives, regulators, and innovators.

Built for the entire HPAPI value chain

Four groups meet in the same room for two days, and each one needs the other three.

Pharma & Biotech

R&D Directors, VP Manufacturing, Heads of Regulatory Affairs, CMC Leads

CMOs & CDMOs

Contract manufacturing leaders specialising in HPAPI handling, containment, and scale-up

Regulatory & EHS

EMA/ECHA compliance teams, occupational health scientists, risk assessment specialists

Tech & Equipment

Containment system vendors, isolator manufacturers, automation & PAT technology providers

HPAPI Manufacturing Containment Engineering Regulatory Affairs Occupational Health & Safety ADC Development Process Analytical Technology Supply Chain & Logistics Automation & Robotics Sustainability & EHS CMO/CDMO Partnerships

Who will be in the room

Based on the delivered Milan editions. The Rome edition is expected to match and exceed these benchmarks.

Audience by sector

Pharma & Biotech
0%
CMOs & CDMOs
0%
Equipment & Tech Vendors
0%
Regulatory & Academia
0%

Seniority breakdown

Senior Leadership (VP+)
0%
Directors & Managers
0%
Scientists & Engineers
0%
Consultants & Others
0%

The industry you operate in is growing fast

$0B
Global HPAPI Market by 2030

Projected market value driven by oncology, ADCs, and precision medicine demand

0%
Market CAGR (2024–2030)

One of the fastest-growing segments across the global pharmaceutical industry

0%+
New Oncology Drugs are HPAPIs

High-potency compounds now dominate oncology drug development pipelines globally

0+
HPAPIs in Development Globally

Active compounds in clinical and pre-clinical development requiring specialist expertise

0B
European HPAPI Investments

Planned CDMO and containment facility investments across Europe over the next 5 years

0%
Rise in Containment Incidents

Reported increase in occupational exposure events underscoring urgency of better containment

Speakers for Milan 2026

Building on the success of the MaxPotent Pharma Summit 2026 — which welcomed keynote presentations from industry leaders including Justin Mason-Home on strategic elements within HPAPI projects — the 2026 edition will feature an expanded faculty of 25+ expert speakers from pharma, biotech, CDMOs, and regulatory bodies. Speakers for May 2026 are currently being confirmed. If you are a recognised expert in HPAPI manufacturing, containment technologies, regulatory compliance, or occupational health, we invite you to apply to speak.

Stream 01

Manufacturing & Containment

Keynotes and technical presentations on next-generation containment systems, facility design, continuous processing, automation, and scale-up strategies for high-potency compounds.

Apply to Speak
Dean Calhoun

Dean Calhoun

CEO

Affygility Solutions, USA

LinkedIn
Tara Dennis

Tara Dennis

Occupational Hygiene Manager

SafeBridge Europe, UK

LinkedIn
Justin Mason-Home

Justin Mason-Home

Director

HPAPI Project Services, UK

LinkedIn
Ana Fernandez

Ana Fernandez

Pharmaceutical Technology Manager

Syntegon Telstar Technologies SLU

LinkedIn
Fabio Zenobi

Fabio Zenobi

EHS Director

BSP Pharmaceuticals S.p.A.

LinkedIn
Roberto Furlan

Roberto Furlan

Sales Manager

CSV Containment

LinkedIn
Giorgio Mari

Giorgio Mari

Senior Process Engineer

Exyte

LinkedIn
Kees Hommes

Kees Hommes

Sr. Occupational Hygienist

OH Consult

LinkedIn
Stream 02

Regulatory, Safety & Compliance

Expert sessions on evolving EMA and ECHA frameworks, risk-based exposure assessments, occupational health management, supply chain resilience, and CDMO partnership models.

Apply to Speak
Speaker Name

Speaker Name

Job Title

Company Name

LinkedIn
Speaker Name

Speaker Name

Job Title

Company Name

LinkedIn
Speaker Name

Speaker Name

Job Title

Company Name

LinkedIn

Agenda at a Glance

Two intensive days spanning the full HPAPI value chain, from regulatory compliance and containment engineering to automation, sustainability and supply chain resilience.

Day 1 · 21st April 2027
08:15
Registration & Networking Coffee
09:00
Chairperson’s Welcome & Opening Remarks
09:10
The Future of Highly Potent Medicines: From HPAPIs to ADCs, Radiopharmaceuticals and Targeted Therapies
09:40
Global Regulatory Expectations for HPAPIs: EMA, FDA, PIC/S and Annex 1 Updates
10:10
Developing Robust Occupational Exposure Limits (OELs), HBELs and PDEs for Next-Generation Molecules
10:40
Networking Coffee Break
Day 2 · 22nd April 2027
08:15
Registration & Networking Coffee
09:00
Opening Remarks by Chairperson
09:10
Keynote: Designing Future-Ready HPAPI Facilities for the Next Decade
09:40
Innovative Containment Technologies for Ultra-Potent Compounds
10:10
Comparing Flexible vs Rigid Isolators: Performance, Cost and Operational Impact
10:40
Networking Coffee Break
🔒

23 more sessions across both days

Add your business email to unlock the full Rome 2027 programme, including every talk title and speaker slot.

    We will send the PDF agenda across as well.

    Drinks Reception

    End of Day 1 from 17:30 — informal, relationship-first networking

    1:1 Meetings

    Structured matchmaking with sponsors, speakers, and delegates

    Networking Lunches

    Shared lunches both days — cross-industry connection opportunity

    Sponsor Exhibition

    Dedicated exhibition space running across both conference days

    View the full two-day programme

    Trusted by Industry Leaders

    Companies who sponsor MaxPotent Pharma Summit to reach a highly concentrated audience of HPAPI decision-makers, technical experts, and contract manufacturing leaders.

    Platinum Sponsors
    Gold Sponsors
    Silver Sponsors
    Exhibitors

    Why sponsor MaxPotent 2026

    Sponsoring MaxPotent Pharma Summit places your brand at the centre of Europe's most focused HPAPI conference, with direct access to 300+ senior decision-makers you cannot reach anywhere else.

    Speaking Access

    Reserved branded speaking slot in the main programme (Platinum & Gold) — 30 minutes on Day 1.

    Exhibition Space

    Dedicated 10×6ft stand for live product demos and direct delegate engagement across both days.

    Attendee List

    Post-event delegate list with contact details for structured follow-up outreach after the summit.

    1:1 Matchmaking

    Up to 10 pre-arranged one-to-one meetings with your most relevant delegates and prospects.

    Brand Visibility

    Logo placement across the website, programme brochure, email campaigns, and all on-site materials.

    Social Media Coverage

    Pre and post-event coverage across MaxPotent's LinkedIn and email channels to 5,000+ subscribers.

    What Sponsors and Delegates Say

    Sponsors, speakers and delegates on the Milan 2026 floor.
    The event was exceptionally well organised, offering ample networking opportunities with a large number of attendees and presenters. The hospitality was excellent, and it was a pleasure to interact with colleagues while highlighting the importance of toxicology in areas such as containment, risk assessment, and both worker and patient protection. We look forward to collaborating with Convolign on future events as well.
    Martin Kohan
    Managing Toxicologist, SafeBridge Europe, UK
    We truly felt we were at the right place. Over the past two days, we had insightful discussions around containment systems. The event brought together many customers, key manufacturers, and leading engineering companies, making it a great platform to exchange knowledge, information, and experience. We will definitely look forward to joining next year’s edition.
    Stefano Butti
    Technical Sales Director, FPS Pharma & Food Systems Srl
    Congratulations to the entire team of Convolign Business Consulting for organising such a wonderful event. It was a perfect platform to gain insights into the key factors and technologies shaping high potent drug manufacturing. We also had excellent opportunities to network with peers and connect with new clients.
    Andrea Confetti
    Chairman, Dipharma Francis Srl
    The event was highly informative, and we made some excellent industry contacts to introduce our systems to. The footfall was impressive, and the presentations were insightful. Overall, it was a great event for us, and we look forward to attending the next edition.
    Mike Shemeld
    Technical Sales Manager, CTS Europe
    We had an excellent delegate turnout. The one-to-one meetings were very well organised and provided a great platform to connect with leaders from across various segments of HPAPI drug development. Truly a valuable opportunity for meaningful discussions and collaborations.
    Roberto Furlan
    Sales Manager, CSV Containment
    I found the event very engaging, with a wide range of interesting topics covered. The venue was excellent, offering plenty of opportunities for networking, and the hospitality was truly remarkable.
    Andrea Weiss
    International Business Strategist, AM Instruments

    60+ Companies Represented to Date

    A snapshot of the organisations that have joined the summit across its first two editions.

    AbbVie Accord Healthcare Adare Pharma Solutions Affygility Solutions APC AstraZeneca Bayer be circular Boehringer Ingelheim Bristol Myers Squibb Chiesi COMBER Process Technology Corden Treviglio Eli Lilly Exyte Ferrero Flamma S.p.A. Genmab GENTEC Pharmaceutical Group Gilead GlaxoSmithKline GMP Check GSK HECHT Technologie GmbH Howorth Air Technology HPAPI Project Services Hunazine Biotech Hyntelo Inke Jacobs Italia Johnson & Johnson Kikusui Europe Landoor Lundbeck Menarini Merck Group Nanozen Industries Novartis Novo Nordisk Octapharma OH Consult Pfizer Pharmanoid Rattinox Srl Ravizza & C Srl Recordati Roche SafeBridge Europe Sanofi Sartorius Swati Spentose Takeda TEVA – TAPI Teva Pharmaceuticals TheaPharma Thermo Fisher Scientific ToxHub Srl TransPerfect UCB Pharma Veolia Water Technologies Vis Viva s.r.l. Zoetis

    Why Rome for the Third Edition

    The summit series moves to Rome for its third edition. Here is what that changes for the people travelling to it.

    The first two editions proved the format in Milan, at the centre of Italy’s API manufacturing cluster. Rome widens the door. It is the best-connected city in Italy for international delegates, with two airports carrying direct flights from across Europe, the Americas and Asia, so the CDMO partners, regulators and technology providers who could not easily reach Milan can now attend without a connecting flight. Rome also puts the summit alongside the Lazio pharmaceutical corridor and within reach of the regulatory community, while offering the conference capacity and hotel choice that a growing delegation needs.

    01

    Two international airports

    Rome Fiumicino (FCO) is Italy’s largest hub, with direct long-haul routes; Ciampino (CIA) adds low-cost European connections. Both are around 30 to 45 minutes from the centre.

    02

    High-speed rail across Italy

    Roma Termini connects to Milan in about three hours, plus Florence, Bologna, Naples and Venice, so delegates can combine the summit with site visits.

    03

    A pharmaceutical corridor

    Lazio hosts one of Italy’s densest concentrations of pharmaceutical manufacturing and contract development, alongside the containment and engineering specialists that serve it.

    04

    Capacity to grow

    Rome gives the summit the conference space, hotel inventory and international flight access to expand the delegation beyond what the previous venues allowed.

    Join us in Rome

    Venue to be announced

    The 3rd Annual MaxPotent Pharma Summit takes place in Rome on 21–22 April 2027. The venue is being finalised. Full venue and accommodation details are shared with registered delegates and confirmed sponsors as soon as they are confirmed.

    Rome, Lazio, Italy
    21–22 April 2027 · Registration from 08:15
    Served by Rome Fiumicino (FCO) and Ciampino (CIA) airports
    Direct high-speed rail connections from Roma Termini

    Italy, a European HPAPI heartland

    Italy hosts one of Europe’s densest concentrations of API and HPAPI contract manufacturers, from Lombardy to Lazio, alongside the engineering and containment specialists that serve them. That is why the summit series has made Italy its home since the inaugural Milan edition.

    Get in touch
    with our team

    For registration enquiries, speaking opportunities or sponsorship packages, our team is ready to assist.

    Madhumati Patil · +91 98608 51975
    Akshita Lohia ·+1-617-213-1431
    Organised by Convolign Business Consulting LLP · Boston & London